VUMC to research potential allergic reactions in children to COVID-19 vaccine

Participants ages 5 to 17 are needed
Posted at 5:18 AM, Jan 27, 2022
and last updated 2022-01-27 12:30:24-05

NASHVILLE, Tenn. (WTVF) — Pfizer's COVID-19 vaccine has been widely available for children as young as 5 since the fall, but research continues on its impact on those prone to allergic reactions.

Vanderbilt University Medical Center is leading a new study focusing on children who have had allergic reactions to prior vaccines or medications; however, participants with no history of severe allergic reactions are also needed.

Researchers are looking to enroll anyone ages 5 to 17 who has not had the vaccine yet. The study needs about 20 volunteers.

Vanderbilt completed the study with adults and believes it's necessary to look at all ages.

Investigator Dr. Elizabeth Phillips understands families may have a hesitancy to get vaccinations if their child has had a reaction in the past, but she stresses that the trial is a safe place for kids to get their COVID vaccine since they will be closely monitored and observed by the Children's Hospital.

Phillips hopes that level of care provides some comfort to families.

Researchers said it's been more than a year since the start of the vaccine rollout and true allergies associated with the vaccine have proven to be very rare.

Since they cannot assume that highly allergic children will react like highly allergic adults to the vaccine, the study is necessary.

Call 615-831-4277 or email to obtain more information. A pre-screening survey for the study can be found here.